SEC Tracker
Get the app

X4 Pharmaceuticals XFOR

KIRSKE DAVID sells shares

David Kirske, insider filing for XFOR

Form
4
Filed
Importance
Routine
  1. Oct 1, 2026 sale of 11,767 shares
  2. Price range $2.82 to $2.92
  3. 64,418 restricted stock units reported

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when X4 Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Akari Therapeutics AKTX public float $15M, Jun 30, 2025
  2. ProPhase Labs PRPH public float $15M, Jun 30, 2025
  3. Pluri PLUR public float $15M, Dec 31, 2025
  4. CalciMedica CALC public float $16M, Jun 30, 2025
  5. Edesa Biotech EDSA public float $14M, Mar 31, 2025, over 18 months old

Data on this page was fetched . The filing on SEC.gov is the record.